Current NHS and NICE guidance confirms there is no clinical evidence that specific terpenes, or terpene-rich cannabis profiles, can directly relieve dystonia symptoms. According to NICE…
Current NHS and NICE guidance confirms there is no clinical evidence that hemp-derived CBD products effectively treat dystonia, a neurological condition that causes involuntary muscle…
Current NHS and NICE guidance confirms there is no clinical evidence that full-spectrum or isolate cannabis extracts are effective for treating dystonia. According…
Current evidence does not show that dronabinol capsules are more effective than plant-derived cannabis for dystonia. Both contain the active compound THC (tetrahydrocannabinol), but…
Emerging research suggests that balanced THC:CBD formulations may offer better symptom control in dystonia than THC or CBD alone, though clinical evidence remains limited. These…
Evidence from recent studies suggests that THC may provide stronger muscle-relaxant effects than CBD for people with dystonia, though research remains early and inconclusive. Both…